Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
6.201
+0.071 (+1.15%)
Streaming Delayed Price
Updated: 1:11 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Arcturus Therapeutics to Attend Upcoming Investor Conference
November 24, 2025
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics (NASDAQ:ARCT) Reports Mixed Q3 2025 Results, Extends Cash Runway to 2028
↗
November 10, 2025
Arcturus Q3 2025 results show a revenue miss but a smaller-than-expected loss. The company advances its CF and OTC programs, with cash extending into 2028.
Via
Chartmill
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
November 10, 2025
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Preview: Arcturus Therapeutics's Earnings
↗
November 07, 2025
Via
Benzinga
Arcturus Therapeutics to Attend Upcoming Investor Conferences
November 04, 2025
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
October 28, 2025
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. - ARCT
October 24, 2025
From
Pomerantz LLP
Via
GlobeNewswire
This Molina Healthcare Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
↗
October 24, 2025
Via
Benzinga
Cathie Wood Goes Shopping: 3 Stocks She Just Bought
↗
October 23, 2025
The growth-focused money manager only bought three stocks on Wednesday. Let's check out that shopping list.
Via
The Motley Fool
Topics
ETFs
Where Arcturus Therapeutics Stands With Analysts
↗
October 22, 2025
Via
Benzinga
Arcturus' Investigational Inhaled Therapy Lacks Meaningful Lung Function Improvement, Analyst Notes Mixed Picture
↗
October 22, 2025
Arcturus stock drops on interim Phase 2 results for ARCT-032, showing promising mucus reduction in cystic fibrosis patients but no initial FEV₁ improvement.
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
↗
October 22, 2025
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Crude Oil Gains Over 1%; AT&T Shares Slide After Q3 Results
↗
October 22, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 22, 2025
Via
Benzinga
Top movers in Wednesday's session
↗
October 22, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
October 22, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Falls 100 Points; Netflix Shares Tumble On Downbeat Earnings
↗
October 22, 2025
Via
Benzinga
Topics
Stocks
Arcturus Therapeutics Stock Plunges Over 57% Today: What’s Causing The Sell-Off?
↗
October 22, 2025
The company said that treatment-related adverse events were observed in the study for the first few doses but ceased with continuous dosing.
Via
Stocktwits
Arcturus Crashes 55% On 'Underwhelming' Results For mRNA-Tied Cystic Fibrosis Drug
↗
October 22, 2025
The company is working on a treatment for cystic fibrosis using messenger RNA, or mRNA, technology.
Via
Investor's Business Daily
Wednesday's pre-market session: top gainers and losers
↗
October 22, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 22, 2025
Via
Benzinga
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program
October 22, 2025
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 29, 2025
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
September 19, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
↗
September 18, 2025
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),
Via
Benzinga
Topics
Artificial Intelligence
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
September 15, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
September 15, 2025
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NASDAQ:SRPT),(NASDAQ:AUTL),(NASDAQ:ARCT) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Intellectual Property
Forecasting The Future: 5 Analyst Projections For Arcturus Therapeutics
↗
September 04, 2025
Via
Benzinga
Arcturus Therapeutics to Attend Upcoming Investor Conferences
August 26, 2025
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
